Table 2.
Antibiotic, antimycotic, and antiviral treatment during extracorporeal membrane oxygenation (ECMO) use in a patient with HIV/AIDS and severe acute respiratory distress syndrome
| Admission | Day 5 | Day 7 | Day 10 | Day 18 | Day 20 | Day 21 | Day 23 | |
|---|---|---|---|---|---|---|---|---|
| Bacterial pneumonia | ||||||||
| Piperacillin/tazobactam and vancomycin | Piperacillin/tazobactam and vancomycin | Levofloxacin | Levofloxacin | Levofloxacin | Levofloxacin | Levofloxacin | ||
| Novel HIV/AIDS | ||||||||
| Pneumocystis jirovecii pneumonia | SMX + TMP | SMX + TMP | SMX + TMP | SMX + TMP | Pentamidine | Pentamidine | Pentamidine | Pentamidine |
| CMV | Ganciclovir | Ganciclovir | Ganciclovir | Ganciclovir | ||||
| MAC | Azithromycin | Azithromycin | ||||||
| ECMO | ||||||||
| Initiated | Decannulated | |||||||
CMV, cytomegalovirus; MAC, mycobacterium avium complex; SMX, sulfamethoxazole; TMP, trimethoprim.